PULMATRIX, INC. Amortization of Debt Discount (Premium)
PULMATRIX, INC. (PULM) reported Amortization of Debt Discount (Premium) of $0 for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-19.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2019-02-19
- PULMATRIX, INC. amortization of debt discount (premium) for the quarter ending 2018-12-31 was $0.00.
- PULMATRIX, INC. amortization of debt discount (premium) for the quarter ending 2018-09-30 was $0.00.
- PULMATRIX, INC. amortization of debt discount (premium) for the quarter ending 2018-06-30 was $0.00.
- PULMATRIX, INC. amortization of debt discount (premium) for the quarter ending 2018-03-31 was $0.00.
- PULMATRIX, INC. amortization of debt discount (premium) for fiscal 2018 was $0.00.
- PULMATRIX, INC. amortization of debt discount (premium) for fiscal 2017 was $0.00.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $0.00 derived: sum of 2 quarters · filed 2019-02-19 | $0.00 derived: sum of 3 quarters · filed 2019-02-19 | $0.00 10-K · filed 2019-02-19 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $0.00 derived: sum of 2 quarters · filed 2018-11-14 | $0.00 10-Q · filed 2018-11-14 | $0.00 derived: sum of 4 quarters · filed 2018-11-14 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $0.00 10-Q · filed 2018-08-03 | $0.00 derived: sum of 3 quarters · filed 2018-08-03 | $0.00 derived: sum of 4 quarters · filed 2018-08-03 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-11 | $0.00 derived: sum of 2 quarters · filed 2018-05-11 | $0.00 derived: sum of 3 quarters · filed 2018-05-11 | $0.00 derived: sum of 4 quarters · filed 2018-05-11 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $0.00 derived: sum of 2 quarters · filed 2018-03-13 | $0.00 derived: sum of 3 quarters · filed 2018-03-13 | $0.00 10-K · filed 2018-03-13 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | $0.00 10-Q · filed 2017-08-04 | ||
| 2017-03-31 | $0.00 10-Q · filed 2017-05-05 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $0.00 derived: sum of 2 quarters · filed 2016-11-04 | $0.00 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | $0.00 10-Q · filed 2016-08-04 | ||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 | |||
| 2015-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $430.00K 10-Q · filed 2015-11-12 | ||
| 2015-06-30 | $410.00K 10-Q · filed 2015-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |